Niagen Bioscience, Inc. (NAGE) Stock

Consumer Defensive · Packaged Foods · Member of Other US Stocks

Niagen Bioscience, Inc. (NAGE) closed at USD 2.53 on 2026-10-14, a change of -65.2 % over the past year, with a market capitalization of USD 205.48M.

Niagen Bioscience, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Niagen Bioscience, Inc. key figures

Previous close

USD 2.53 (2026-10-14)

1-year change

-65.2 %

Market cap

USD 205.48M

Enterprise value

USD 140.32M

P/E ratio (trailing)

13.58

P/E ratio (forward)

-43.00

EPS (trailing)

0.19

EPS (forward)

-0.06

PEG ratio

n/a

Price to book

2.47

Revenue growth

-4.3 %

Earnings growth

-75 %

Dividend per share (trailing)

0.00

Short ratio

10.10

Employees

117

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Niagen Bioscience, Inc. and compare it with other stocks.